WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A drug previously approved for multiple sclerosis also can treat inflammatory bowel disease in some patients, a new clinical trial reports. The medication, ozanimod (Zeposia), proved effective in helping patients with ulcerative colitis, sending many into full remission, according to results being publishedContinue Reading

WEDNESDAY, Sept. 29, 2021 (HealthDay News) — In a survey of parents in metro Chicago, nearly half of Black parents (48%) said they were reluctant to have their kids vaccinated against COVID-19, researchers say. That’s significantly higher than the 33% of Hispanic parents and 26% of white parents who expressedContinue Reading

WEDNESDAY, Sept. 29, 2021 (American Heart Association News) — For people with heart disease and stroke, COVID-19 vaccines offer protection against the life-threatening disease caused by the coronavirus, and a booster dose could bolster that protection, health experts said. The Centers for Disease Control and Prevention, which sets policy onContinue Reading

Side effects of Pfizer booster shots are no different than with first two doses: The reassuring report comes as millions of Americans sign up for their third dose of the vaccine. Read more New tests for colon, prostate cancer show promise: In a pair of studies, just a sample ofContinue Reading

WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Roughly a third of Americans on high blood pressure medications do not have their blood pressure under control, a new study reveals. And younger men and older women are particularly vulnerable, researchers warn. “Although this phenomenon has been hinted at in the medicalContinue Reading